Skip to content

Business · AU · 16:41

CSL could spend up to $2.2b on drug deal with Swiss biotech start-up

The Australian Financial Review · Business

Published 5 Oct 2026, 16:41 AEDT

CSL could spend up to $2.2b on drug deal with Swiss biotech start-up — Photo: The Australian Financial Review / source, © The Australian Financial Review.

Read it at the source

The Australian Financial Review↗

We link out rather than republish. The reporting belongs to the publications above; the summary and the search data on this page are ours.

More trending now

Politics · 16:42Is Anthony Albanese destined to be the most disappointing prime minister ever? | First Dog on the MoonThe Guardian Australia · PoliticsThe Guardian Australia↗

Politics · 15:00Young Australian caught up in IS could come home on passport soonSMH.com.au · PoliticsSMH.com.au↗

Politics · 12:07Bolsonaro defies expectations in Brazil presidential vote to face Lula in run-offABC News · PoliticsABC News↗

World · 11:58Trump’s bluff is too late to save himSMH.com.au · WorldSMH.com.au↗

World · 16:59Police investigating Flydubai co-pilot’s Australia tiesAl Jazeera · WorldAl Jazeera↗

Sport · 09:37'Don't drop it': Star's nervous moment as Roosters celebrate in BondiABC News · SportABC News↗

Sport · 08:28Merrett becomes a Hawk in shock late deal on day one of AFL trade periodABC News · SportABC News↗

Sport · 08:13What to look for during the AFL trade periodABC News · SportABC News↗

120sec · About · Editorial · Corrections · Contact · Privacy · Cookies